| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 04/05/2006 | EP1641742A2 Compounds that selectively bind to membranes of apoptotic cells |
| 04/05/2006 | EP1641431A2 Uses of il-12 in hematopoiesis |
| 04/05/2006 | EP1641430A2 Gelled starch compositions and methods of making gelled starch compositions |
| 04/05/2006 | EP1641424A2 Programmed immune responses using a vaccination node |
| 04/05/2006 | EP1641423A2 Benzodiazepine cgrp receptor antagonists |
| 04/05/2006 | EP1641422A2 Interleukin-21 analogs |
| 04/05/2006 | EP1596875A4 Tertiary amine functional complex polyester polymers and methods of production and use |
| 04/05/2006 | EP1333805B1 Cosmetic method of treating skin |
| 04/05/2006 | EP1330249B1 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof |
| 04/05/2006 | EP1294720B1 Non-nucleoside reverse transcriptase inhibitors |
| 04/05/2006 | EP0800397B1 Bone mass anabolic composition comprising olpadronate |
| 04/05/2006 | CN1756719A Novel method and device for silicon dioxide from rice husk ash |
| 04/05/2006 | CN1756564A Method of treating autoimmune disease by inducing antigen presentation by tolerance inducing antigen presenting cells |
| 04/05/2006 | CN1756558A Combination therapy for treating protein deficiency disorders |
| 04/05/2006 | CN1754880A Process for preparing 2-iminopyrrolidine derivatives |
| 04/05/2006 | CN1249081C Glycopeptide derivatives and pharmaceutical compositions containing same |
| 04/05/2006 | CN1249074C 2-aminocarbonyl-9H-punine derivatives |
| 04/05/2006 | CN1248734C Matrix protein compositions for wound healing |
| 04/04/2006 | US7022695 Thioether-substituted benzamides as inhibitors of Factor Xa |
| 04/04/2006 | US7022686 A1 adenosine receptro antagonists |
| 04/04/2006 | US7022663 Comprising as active ingredient a therapeutically effective amount of Copolymer 1 (glatiramer acetate), and microcrystalline cellulose; treatment of autoimmune diseases |
| 04/04/2006 | US7022500 Humanized immunoglobulins |
| 04/04/2006 | US7022488 Functional coupling of T1Rs and T2Rs by Gi proteins, and cells-based assays for the identification of T1R and T2R modulators |
| 04/04/2006 | US7022340 Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| 04/04/2006 | CA2291075C Use of 1-ar(alk)yl-imidazolin-2-one for treating anxiety and stress conditions |
| 03/30/2006 | WO2005055955A3 DOSING METHODS FOR ß-D-2’,3’-DIDEOXY-2’,3’-DIDEHYDRO-5-FLUOROCYTIDINE ANTIVIRAL THERAPY |
| 03/30/2006 | WO2005055946A3 Glycopegylated granulocyte colony stimulating factor |
| 03/30/2006 | WO2005048946A3 Treatment for burn victims and animal carcasses |
| 03/30/2006 | WO2005048942A3 Combination therapy comprising a cox-2 inhibitor and an antineoplastic agent |
| 03/30/2006 | WO2005048935A3 Methods of modulating immunity |
| 03/30/2006 | WO2005046573A3 Pro104 antibody compositions and methods of use |
| 03/30/2006 | WO2005027851A3 Treatment of severe distal colitis |
| 03/30/2006 | WO2005025510A3 Cox-2 selective inhibitor with extended duration |
| 03/30/2006 | WO2005020912A3 Delivery of immune response modifier compounds |
| 03/30/2006 | WO2005013898A3 Novel targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax |
| 03/30/2006 | WO2005013896A3 Programmed immune responses using a vaccination node |
| 03/30/2006 | WO2005009360A3 Compositions related to a novel endophytic fungi and methods of use |
| 03/30/2006 | WO2005007087A3 Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulators |
| 03/30/2006 | WO2004089297A3 Compounds and methods for treatment of thrombosis |
| 03/30/2006 | WO2004071417A3 Inhibitors of candida albicans |
| 03/30/2006 | WO2004037196A3 Cytomodulating peptides and methods for treating neurological disorders |
| 03/30/2006 | US20060069256 Ophthalmic compositions for treating ocular hypertension |
| 03/30/2006 | US20060069245 Screening methods for cognitive enhancers |
| 03/30/2006 | US20060069116 3-Amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/30/2006 | US20060069088 Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors |
| 03/30/2006 | US20060069075 Methods for treating dry eye |
| 03/30/2006 | US20060068035 Method of preparation and composition of a water soluble extract of the bioactive component of the plant species Uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals |
| 03/30/2006 | US20060067944 Stable immunogenic product comprising antigenic heterocomplexes |
| 03/29/2006 | EP1639141A2 Methods for treating lentivirus infections |
| 03/29/2006 | EP1639109A2 Dna vectors |
| 03/29/2006 | EP1638987A2 Nucleic acid sequences encoding and compositions comprising ige signal peptide and/or il-15 and methods for using the same |
| 03/29/2006 | EP1638960A2 Preparation of chemical compounds |
| 03/29/2006 | EP1638950A2 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 03/29/2006 | EP1638938A2 Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases |
| 03/29/2006 | EP1638910A2 Color stabilization of hydroquinone hydroxyethyl ether products |
| 03/29/2006 | EP1638605A2 Delivery of therapeutic compounds to the brain and other tissues |
| 03/29/2006 | EP1638590A2 Immune enhancing composition containing lactoferrin |
| 03/29/2006 | EP1638589A2 Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis |
| 03/29/2006 | EP1638587A2 Contraceptive methods and compositions related to proteasomal interference |
| 03/29/2006 | EP1638578A2 Hydrolytically-resistant boron-containing therapeutics and methods of use |
| 03/29/2006 | EP1638573A2 Use of selective cyclooxygenase-2 inhibitors for the treatment of endometriosis |
| 03/29/2006 | EP1638551A2 Immunosuppressant compounds and compositions |
| 03/29/2006 | EP1638549A2 Novel antibacterial agents |
| 03/29/2006 | EP1638530A2 Drug polymer complexes |
| 03/29/2006 | EP1638529A2 Oral extended-release composition |
| 03/29/2006 | EP1638517A2 Peptides antibodies directed thereagainst and methods using same for diagnosing and treating amyloid-associated diseases |
| 03/29/2006 | EP1638512A2 Ligands that bind to the amyloid-beta; precursor peptide and related molecules and uses thereof |
| 03/29/2006 | EP1638510A2 Multivalent carriers of bi-specific antibodies |
| 03/29/2006 | EP1638509A2 Thermally stable crystalline epirubicin hydrochloride and method of making the same |
| 03/29/2006 | EP1638507A2 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 03/29/2006 | EP1638505A2 Amphiphilic pyridinium compounds, method of making and use thereof |
| 03/29/2006 | EP1638492A2 Preoperative treatment of post operative pain |
| 03/29/2006 | EP1638491A2 Deployable multifunctional hemostatic agent |
| 03/29/2006 | EP1347765B1 Dermatological aqueous formulations containing clindamycin and a water soluble zinc salt |
| 03/29/2006 | CN1754002A Methods and compositions concerning poxviruses and cancer |
| 03/29/2006 | CN1753880A Diarylcycloalkyl derivatives, process for their preparation and their use as pharmaceuticals |
| 03/29/2006 | CN1753692A Lymphotoxin beta receptor agents in combination with chemotherapeutic agents |
| 03/29/2006 | CN1753691A Subcutaneously-administered ganglioside-based vaccine compositions |
| 03/29/2006 | CN1753689A The use of cytochrome p450 enzyme cyp2wi as a drug traget for cancer therapy |
| 03/29/2006 | CN1753673A Prodrugs of gaba analogs, compositions and uses thereof |
| 03/29/2006 | CN1753660A The use of antimuscarinic drugs |
| 03/29/2006 | CN1247537C Process for preparation 3-aryl-2-hydroxypropionic acid derivative |
| 03/29/2006 | CN1247190C Immediate release tablet cores of insoluble drugs having sustained release coating |
| 03/28/2006 | US7018640 Vaccinating a domesticated bird against coccidiosis comprising administering in ovo, during the final quarter of incubation, an effective immunizing dose of live Eimeria sporozoites or merozoites, or a mixture |
| 03/28/2006 | US7018638 Mycoplasma hyopneumoniae bacterin vaccine |
| 03/28/2006 | US7018618 An aerosol solution composition for use in an aerosol inhaler comprises an active material, a propellant containing a hydrofluoroalkane, a cosolvent and optionally a low volatility component to increase the mass median aerodynamic diameter of |
| 03/28/2006 | CA2290963C S-omeprazole magnesium trihydrate |
| 03/28/2006 | CA2290392C Salts of optically active sulfoxide derivative |
| 03/23/2006 | WO2006031195A1 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children. |
| 03/23/2006 | WO2006031191A1 Compositions comprising compounds capable of forming a reversible bond or association with gaseous nitric oxide |
| 03/23/2006 | WO2005052131A3 C140rf35 as modifier of the beta catenin pathway and methods of use |
| 03/23/2006 | WO2005048945A3 Hydroxylamine substituted imidazo ring compounds |
| 03/23/2006 | WO2005046585A3 Vps35-based assays and methods for treating alzheimer’s disease |
| 03/23/2006 | WO2005044187A3 Inhalable pharmaceutical formulations employing lactose anhydrate and methods of administering the same |
| 03/23/2006 | WO2005041903A3 Methods and reagents for diagnosis and treatment of diabetes |
| 03/23/2006 | WO2005037209A3 A method for the separation anti-amyloid beta antibody with amyloid beta peptide |
| 03/23/2006 | WO2005013886A3 Methods for treating and preventing apoptosis-related diseases using rna interfering agents |
| 03/23/2006 | WO2005000250A3 Imaging agents and methods of imaging alpha 7-nicotinic cholinergic receptor |
| 03/23/2006 | WO2005000201A3 Modulation of apolipoprotein (a) expression |
| 03/23/2006 | WO2004112721A3 Prevention or treatment of deficits that arise in connection with diseases of, or injuries to, the nervous system |